| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.076 | 0.2 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.2 |